Announcements and Notices - [Other - Business Update]

Simcere Pharmaceutical Group manufactures and supplies branded generic pharmaceuticals to the China market. The Company's products include antibiotics, anti-cancer medications and anti-stroke medications.

Voluntary Announcement - Entering Into An Exclusive License Agreement With Vigonvita For New Indications Of Deuterated Remdesivir Hydrobromide

Announcements and Notices - [Share Scheme]

Grant Of Awards Under The 2021 Rsu Scheme

Announcements and Notices - [Continuing Connected Transaction]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Simcere Pharmaceutical Group (2096 HK)

Voluntary Announcement - Entering Into An Exclusive License Agreement With Vigonvita For New Indications Of Deuterated Remdesivir Hydrobromide

Grant Of Awards Under The 2021 Rsu Scheme

Further Revision Of The 2025 And 2026 Annual Caps Of Exclusive Promotion Services Cooperation Agreement

Notification Letter And Reply Form To Non-Registered Holders: Notice Of Publication Of Interim Report 2025

Notification Letter And Reply Form To Registered Shareholders: Notice Of Publication Of Interim Report 2025

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)